Results for tag: "Managed Entry Agreement"

Managed Entry Agreements (MEAs) are contractual arrangements between pharmaceutical companies and health insurers or other payers that allow for the introduction of new drugs into the market. MEAs are used to manage the cost of new drugs and to ensure that they are used appropriately. MEAs typically involve the pharmaceutical company providing discounts or rebates to the payer in exchange for the payer agreeing to cover the drug. The payer may also agree to limit the use of the drug to certain patient populations or to limit the use of competing drugs. MEAs are an important tool in managed care, as they allow payers to manage the cost of new drugs while ensuring that they are used appropriately. Some companies in the Managed Entry Agreement market include CVS Health, Express Scripts, OptumRx, and UnitedHealth Group. Show Less Read more